Continuing Education PROGRAM Gynecology Health Forum for Pharmacists

By Dr. Jamie Kroft, MD, FRCSC and Kerry Roberts, Pharmacist

Learning Objectives:

1. Determine the impact of uterine fibroids, endometriosis, and contraception on gynecologic health.

2. Direct patients on the appropriate use and potential side effects of pharmacotherapy for endometriosis and uterine fibroids.

3. Guide patients on the appropriate use, risks, and benefits of contraception, including combined oral contraceptives.

4. Understand how best to communicate with patients regarding the use of contraception and pharmacotherapy for uterine fibroids and endometriosis.

This program is made possible through funding from AbbVie Corporation

New therapies for the management of your patients with moderate to severe atopic dermatitis

By Michael Boivin, BSc. Pharm, Dan Tam Vu, B. Pharm and Melinda Gooderham, MD, FRCPC

Upon successful completion of this program, the pharmacist will be better able to:

1. Identify patients with moderate to severe atopic dermatitis (AD, eczema) who may require treatment adjustment or the addition of new agents to reach goals of therapy

2. Review the impact of moderate to severe AD on a patient’s quality of life (itching, sleep, etc.)

3. Discuss the limitations of topical therapies in managing patients with moderate to severe AD

4. Determine which patients with AD should be referred to their primary care provider for changes to the AD treatment plan or the potential addition of new therapy

5. Counsel patients on the different systemic therapy options for patients with moderate to severe AD

This learning activity has received financial support from Abbvie in the form of an unrestricted educational grant

By Suzanne Singh, BScPhm, ACPR, PharmD, RPh